Combined Effects of Oxaliplatin and Tetracaine on Proliferation and Migration in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen, progesterone, and HER2 receptors, presenting significant challenges in treatment due to a lack of targeted therapies. This study investigates the combination effects of oxaliplatin, a platinum-based...